Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
EV/Core EBITDA

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 9.0215.6812.236.325.18

What is the latest EV/Core EBITDA ratio of MARKSANS PHARMA ?

The latest EV/Core EBITDA ratio of MARKSANS PHARMA is 9.02 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar20269.02
Mar202515.68
Mar202412.23
Mar20236.32
Mar20225.18

How is EV/Core EBITDA of MARKSANS PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 9.02
-42.47
Mar2025 15.68
28.21
Mar2024 12.23
93.51
Mar2023 6.32
22.01
Mar2022 5.18 -

Other Financial Ratios of MARKSANS PHARMA


Compare EV/Core EBITDA ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹14,237.3 Cr 2% -4.3% 93% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,620.0 Cr -0.2% -5.1% 8.4% Stock Analytics
DIVIS LABORATORIES ₹239,714.0 Cr -3.8% -3.2% 51.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,741.0 Cr -1.7% -7.7% 29.9% Stock Analytics
CIPLA ₹106,061.0 Cr 0.6% -3.8% -11% Stock Analytics
DR REDDYS LABORATORIES ₹101,339.0 Cr 2.9% 4.6% 0.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

2%

-4.3%

93%

SENSEX

0.2%

-2.8%

-11.2%


You may also like the below Video Courses